 | • レポートコード：MRC2Q12-17713 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、薬物送達用リポソームのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 薬物送達用リポソームのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 薬物送達用リポソームの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 薬物送達用リポソームのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの薬物送達用リポソームの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の薬物送達用リポソームの売上および2028年までの予測に焦点を当てています。 薬物送達用リポソームのグローバル主要企業には、Lipoid Kosmetik、Lucas Meyer Cosmetics、Nippon Fine Chemical、Enoc Solutions、Nanovec、Lipotec、Croda、H&A Pharmachem、Lipomize、ID bio、BioSpectrum、Derma Clinical、Kewpie Corporation、Nanohealth Biotech、Creative Biostructure、Phenbiox、NOF CORPORATION、KYOWA PHARMA CHEMICAL、Nikko Chemicalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 薬物送達用リポソーム市場は、タイプとアプリケーションによって区分されます。世界の薬物送達用リポソーム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他 【アプリケーション別セグメント】 親水性医薬品、疎水性医薬品 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 薬物送達用リポソーム製品概要 - タイプ別市場（リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他） - アプリケーション別市場（親水性医薬品、疎水性医薬品） - 調査の目的 ・エグゼクティブサマリー - 世界の薬物送達用リポソーム販売量予測2017-2028 - 世界の薬物送達用リポソーム売上予測2017-2028 - 薬物送達用リポソームの地域別販売量 - 薬物送達用リポソームの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別薬物送達用リポソーム販売量 - 主要メーカー別薬物送達用リポソーム売上 - 主要メーカー別薬物送達用リポソーム価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（リポソームビタミン、リポソームセラミド、リポソームCoQ10、その他） - 薬物送達用リポソームのタイプ別販売量 - 薬物送達用リポソームのタイプ別売上 - 薬物送達用リポソームのタイプ別価格 ・アプリケーション別市場規模（親水性医薬品、疎水性医薬品） - 薬物送達用リポソームのアプリケーション別販売量 - 薬物送達用リポソームのアプリケーション別売上 - 薬物送達用リポソームのアプリケーション別価格 ・北米市場 - 北米の薬物送達用リポソーム市場規模（タイプ別、アプリケーション別） - 主要国別の薬物送達用リポソーム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの薬物送達用リポソーム市場規模（タイプ別、アプリケーション別） - 主要国別の薬物送達用リポソーム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の薬物送達用リポソーム市場規模（タイプ別、アプリケーション別） - 主要国別の薬物送達用リポソーム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の薬物送達用リポソーム市場規模（タイプ別、アプリケーション別） - 主要国別の薬物送達用リポソーム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの薬物送達用リポソーム市場規模（タイプ別、アプリケーション別） - 主要国別の薬物送達用リポソーム市場規模（トルコ、サウジアラビア） ・企業情報 Lipoid Kosmetik、Lucas Meyer Cosmetics、Nippon Fine Chemical、Enoc Solutions、Nanovec、Lipotec、Croda、H&A Pharmachem、Lipomize、ID bio、BioSpectrum、Derma Clinical、Kewpie Corporation、Nanohealth Biotech、Creative Biostructure、Phenbiox、NOF CORPORATION、KYOWA PHARMA CHEMICAL、Nikko Chemicals ・産業チェーン及び販売チャネル分析 - 薬物送達用リポソームの産業チェーン分析 - 薬物送達用リポソームの原材料 - 薬物送達用リポソームの生産プロセス - 薬物送達用リポソームの販売及びマーケティング - 薬物送達用リポソームの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 薬物送達用リポソームの産業動向 - 薬物送達用リポソームのマーケットドライバー - 薬物送達用リポソームの課題 - 薬物送達用リポソームの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Liposomes for Drug Delivery is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Liposomes for Drug Delivery is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Liposomes for Drug Delivery is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Liposomes for Drug Delivery include Lipoid Kosmetik, Lucas Meyer Cosmetics, Nippon Fine Chemical, Enoc Solutions, Nanovec, Lipotec, Croda, H&A Pharmachem and Lipomize, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Liposomes for Drug Delivery manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Liposomes for Drug Delivery market. Further, it explains the major drivers and regional dynamics of the global Liposomes for Drug Delivery market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Liposomes for Drug Delivery Segment by Type
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Liposomes for Drug Delivery Segment by Application
Hydrophilic Drugs
Hydrophobic Drugs
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Liposomes for Drug Delivery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Liposomes for Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Liposomes for Drug Delivery, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Liposomes for Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposomes for Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Liposomes for Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Liposomes for Drug Delivery sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lipoid Kosmetik, Lucas Meyer Cosmetics, Nippon Fine Chemical, Enoc Solutions, Nanovec, Lipotec, Croda, H&A Pharmachem and Lipomize, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liposomes for Drug Delivery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Liposomes for Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposomes for Drug Delivery sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Liposomes for Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposomes for Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liposome Vitamin
1.2.3 Liposome Ceramide
1.2.4 Liposome CoQ10
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomes for Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hydrophilic Drugs
1.3.3 Hydrophobic Drugs
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposomes for Drug Delivery Sales Estimates and Forecasts 2017-2028
2.2 Global Liposomes for Drug Delivery Revenue Estimates and Forecasts 2017-2028
2.3 Global Liposomes for Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Liposomes for Drug Delivery Sales by Region
2.4.1 Global Liposomes for Drug Delivery Sales by Region (2017-2022)
2.4.2 Global Sales Liposomes for Drug Delivery by Region (2023-2028)
2.5 Global Liposomes for Drug Delivery Revenue by Region
2.5.1 Global Liposomes for Drug Delivery Revenue by Region (2017-2022)
2.5.2 Global Liposomes for Drug Delivery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Liposomes for Drug Delivery Sales by Manufacturers
3.1.1 Global Top Liposomes for Drug Delivery Manufacturers by Sales (2017-2022)
3.1.2 Global Liposomes for Drug Delivery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liposomes for Drug Delivery in 2021
3.2 Global Liposomes for Drug Delivery Revenue by Manufacturers
3.2.1 Global Liposomes for Drug Delivery Revenue by Manufacturers (2017-2022)
3.2.2 Global Liposomes for Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Liposomes for Drug Delivery Revenue in 2021
3.3 Global Liposomes for Drug Delivery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Liposomes for Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Liposomes for Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liposomes for Drug Delivery Sales by Type
4.1.1 Global Liposomes for Drug Delivery Historical Sales by Type (2017-2022)
4.1.2 Global Liposomes for Drug Delivery Forecasted Sales by Type (2023-2028)
4.1.3 Global Liposomes for Drug Delivery Sales Market Share by Type (2017-2028)
4.2 Global Liposomes for Drug Delivery Revenue by Type
4.2.1 Global Liposomes for Drug Delivery Historical Revenue by Type (2017-2022)
4.2.2 Global Liposomes for Drug Delivery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Liposomes for Drug Delivery Revenue Market Share by Type (2017-2028)
4.3 Global Liposomes for Drug Delivery Price by Type
4.3.1 Global Liposomes for Drug Delivery Price by Type (2017-2022)
4.3.2 Global Liposomes for Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Liposomes for Drug Delivery Sales by Application
5.1.1 Global Liposomes for Drug Delivery Historical Sales by Application (2017-2022)
5.1.2 Global Liposomes for Drug Delivery Forecasted Sales by Application (2023-2028)
5.1.3 Global Liposomes for Drug Delivery Sales Market Share by Application (2017-2028)
5.2 Global Liposomes for Drug Delivery Revenue by Application
5.2.1 Global Liposomes for Drug Delivery Historical Revenue by Application (2017-2022)
5.2.2 Global Liposomes for Drug Delivery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Liposomes for Drug Delivery Revenue Market Share by Application (2017-2028)
5.3 Global Liposomes for Drug Delivery Price by Application
5.3.1 Global Liposomes for Drug Delivery Price by Application (2017-2022)
5.3.2 Global Liposomes for Drug Delivery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Liposomes for Drug Delivery Market Size by Type
6.1.1 North America Liposomes for Drug Delivery Sales by Type (2017-2028)
6.1.2 North America Liposomes for Drug Delivery Revenue by Type (2017-2028)
6.2 North America Liposomes for Drug Delivery Market Size by Application
6.2.1 North America Liposomes for Drug Delivery Sales by Application (2017-2028)
6.2.2 North America Liposomes for Drug Delivery Revenue by Application (2017-2028)
6.3 North America Liposomes for Drug Delivery Market Size by Country
6.3.1 North America Liposomes for Drug Delivery Sales by Country (2017-2028)
6.3.2 North America Liposomes for Drug Delivery Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Liposomes for Drug Delivery Market Size by Type
7.1.1 Europe Liposomes for Drug Delivery Sales by Type (2017-2028)
7.1.2 Europe Liposomes for Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Liposomes for Drug Delivery Market Size by Application
7.2.1 Europe Liposomes for Drug Delivery Sales by Application (2017-2028)
7.2.2 Europe Liposomes for Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Liposomes for Drug Delivery Market Size by Country
7.3.1 Europe Liposomes for Drug Delivery Sales by Country (2017-2028)
7.3.2 Europe Liposomes for Drug Delivery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Liposomes for Drug Delivery Market Size by Type
8.1.1 Asia Pacific Liposomes for Drug Delivery Sales by Type (2017-2028)
8.1.2 Asia Pacific Liposomes for Drug Delivery Revenue by Type (2017-2028)
8.2 Asia Pacific Liposomes for Drug Delivery Market Size by Application
8.2.1 Asia Pacific Liposomes for Drug Delivery Sales by Application (2017-2028)
8.2.2 Asia Pacific Liposomes for Drug Delivery Revenue by Application (2017-2028)
8.3 Asia Pacific Liposomes for Drug Delivery Market Size by Region
8.3.1 Asia Pacific Liposomes for Drug Delivery Sales by Region (2017-2028)
8.3.2 Asia Pacific Liposomes for Drug Delivery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Liposomes for Drug Delivery Market Size by Type
9.1.1 Latin America Liposomes for Drug Delivery Sales by Type (2017-2028)
9.1.2 Latin America Liposomes for Drug Delivery Revenue by Type (2017-2028)
9.2 Latin America Liposomes for Drug Delivery Market Size by Application
9.2.1 Latin America Liposomes for Drug Delivery Sales by Application (2017-2028)
9.2.2 Latin America Liposomes for Drug Delivery Revenue by Application (2017-2028)
9.3 Latin America Liposomes for Drug Delivery Market Size by Country
9.3.1 Latin America Liposomes for Drug Delivery Sales by Country (2017-2028)
9.3.2 Latin America Liposomes for Drug Delivery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Liposomes for Drug Delivery Market Size by Type
10.1.1 Middle East and Africa Liposomes for Drug Delivery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Liposomes for Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East and Africa Liposomes for Drug Delivery Market Size by Application
10.2.1 Middle East and Africa Liposomes for Drug Delivery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Liposomes for Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East and Africa Liposomes for Drug Delivery Market Size by Country
10.3.1 Middle East and Africa Liposomes for Drug Delivery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Liposomes for Drug Delivery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Lipoid Kosmetik
11.1.1 Lipoid Kosmetik Corporation Information
11.1.2 Lipoid Kosmetik Overview
11.1.3 Lipoid Kosmetik Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Lipoid Kosmetik Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lipoid Kosmetik Recent Developments
11.2 Lucas Meyer Cosmetics
11.2.1 Lucas Meyer Cosmetics Corporation Information
11.2.2 Lucas Meyer Cosmetics Overview
11.2.3 Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lucas Meyer Cosmetics Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lucas Meyer Cosmetics Recent Developments
11.3 Nippon Fine Chemical
11.3.1 Nippon Fine Chemical Corporation Information
11.3.2 Nippon Fine Chemical Overview
11.3.3 Nippon Fine Chemical Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nippon Fine Chemical Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nippon Fine Chemical Recent Developments
11.4 Enoc Solutions
11.4.1 Enoc Solutions Corporation Information
11.4.2 Enoc Solutions Overview
11.4.3 Enoc Solutions Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Enoc Solutions Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Enoc Solutions Recent Developments
11.5 Nanovec
11.5.1 Nanovec Corporation Information
11.5.2 Nanovec Overview
11.5.3 Nanovec Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nanovec Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nanovec Recent Developments
11.6 Lipotec
11.6.1 Lipotec Corporation Information
11.6.2 Lipotec Overview
11.6.3 Lipotec Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lipotec Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lipotec Recent Developments
11.7 Croda
11.7.1 Croda Corporation Information
11.7.2 Croda Overview
11.7.3 Croda Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Croda Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Croda Recent Developments
11.8 H&A Pharmachem
11.8.1 H&A Pharmachem Corporation Information
11.8.2 H&A Pharmachem Overview
11.8.3 H&A Pharmachem Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 H&A Pharmachem Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 H&A Pharmachem Recent Developments
11.9 Lipomize
11.9.1 Lipomize Corporation Information
11.9.2 Lipomize Overview
11.9.3 Lipomize Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Lipomize Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lipomize Recent Developments
11.10 ID bio
11.10.1 ID bio Corporation Information
11.10.2 ID bio Overview
11.10.3 ID bio Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 ID bio Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 ID bio Recent Developments
11.11 BioSpectrum
11.11.1 BioSpectrum Corporation Information
11.11.2 BioSpectrum Overview
11.11.3 BioSpectrum Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 BioSpectrum Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BioSpectrum Recent Developments
11.12 Derma Clinical
11.12.1 Derma Clinical Corporation Information
11.12.2 Derma Clinical Overview
11.12.3 Derma Clinical Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Derma Clinical Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Derma Clinical Recent Developments
11.13 Kewpie Corporation
11.13.1 Kewpie Corporation Corporation Information
11.13.2 Kewpie Corporation Overview
11.13.3 Kewpie Corporation Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Kewpie Corporation Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Kewpie Corporation Recent Developments
11.14 Nanohealth Biotech
11.14.1 Nanohealth Biotech Corporation Information
11.14.2 Nanohealth Biotech Overview
11.14.3 Nanohealth Biotech Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Nanohealth Biotech Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Nanohealth Biotech Recent Developments
11.15 Creative Biostructure
11.15.1 Creative Biostructure Corporation Information
11.15.2 Creative Biostructure Overview
11.15.3 Creative Biostructure Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Creative Biostructure Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Creative Biostructure Recent Developments
11.16 Phenbiox
11.16.1 Phenbiox Corporation Information
11.16.2 Phenbiox Overview
11.16.3 Phenbiox Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Phenbiox Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Phenbiox Recent Developments
11.17 NOF CORPORATION
11.17.1 NOF CORPORATION Corporation Information
11.17.2 NOF CORPORATION Overview
11.17.3 NOF CORPORATION Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 NOF CORPORATION Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 NOF CORPORATION Recent Developments
11.18 KYOWA PHARMA CHEMICAL
11.18.1 KYOWA PHARMA CHEMICAL Corporation Information
11.18.2 KYOWA PHARMA CHEMICAL Overview
11.18.3 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 KYOWA PHARMA CHEMICAL Recent Developments
11.19 Nikko Chemicals
11.19.1 Nikko Chemicals Corporation Information
11.19.2 Nikko Chemicals Overview
11.19.3 Nikko Chemicals Liposomes for Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Nikko Chemicals Liposomes for Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Nikko Chemicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Liposomes for Drug Delivery Industry Chain Analysis
12.2 Liposomes for Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposomes for Drug Delivery Production Mode & Process
12.4 Liposomes for Drug Delivery Sales and Marketing
12.4.1 Liposomes for Drug Delivery Sales Channels
12.4.2 Liposomes for Drug Delivery Distributors
12.5 Liposomes for Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Liposomes for Drug Delivery Industry Trends
13.2 Liposomes for Drug Delivery Market Drivers
13.3 Liposomes for Drug Delivery Market Challenges
13.4 Liposomes for Drug Delivery Market Restraints
14 Key Findings in The Global Liposomes for Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer